In one analysis from the '211 study, 40 percent of patients treated with BLINCYTO who achieved a complete remission or complete remission with partial hematologic recovery were enabled to proceed to allogeneic hematopoietic stem cell transplant . Additionally, a secondary analysis from the study found that 82 percent of patients who had a CR or CRh also had a minimal residual disease response, a measure used to predict disease recurrence in patients with ALL.
http://ift.tt/12GKnT6
http://ift.tt/12GKnT6
No comments:
Post a Comment